The findings that tumor suppressors such as p53 and BRCA1-associated protein 1 (BAP1) engage ferroptosis in tumor suppression establish ferroptosis as a natural barrier to tumor development, highlighting the great potential of targeting ferroptosis for cancer therapy [5, 6]. The gene discussed is TP53; the disease is neoplasm.